Research Studies » Moderate-to-Severe Atopic Dermatitis

Living with Atopic Dermatitis can be challenging, but you can help advance vital research while exploring new treatment options. We are enrolling participants for a study evaluating a new medication for moderate to severe Atopic Dermatitis. Study related medication is provided at no cost, and you will be compensated for your time and travel if you qualify.

To qualify, participants should:

  • Be 12 years of age or older

  • Have been diagnosed with moderate to severe Atopic Dermatitis (Eczema)

Qualified participants will receive:

  • Compensation available for eligible participants

  • Comprehensive Support: Regular health check-ins and assessments by experienced healthcare professionals dedicated to your well-being

  • No-Cost Study Medications: Study-related medication for moderate to severe Atopic Dermatitis provided at no cost

Powered By RealTime-CTMS Clinical Trial Management System